Report Overview

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.

The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray.

The global Nasal Spray Vaccine revenue was US$ 136.8 million in 2022 and is forecast to a readjusted size of US$ 231.3 million by 2029 with a CAGR of 7.7% during the forecast period (2023-2029).

In India, the Nasal Spray Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal Spray Vaccine is for Adult, and the consumption proportion is about 68% in 2019.

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

This report focuses on global and India Nasal Spray Vaccine market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Nasal Spray Vaccine will continue to grow rapidly in the future.

Global Nasal Spray Vaccine Scope and Market Size

Nasal Spray Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Nasal Spray Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Nasal Spray Vaccine market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

By Company

AstraZeneca FLUMIST

Cipla

BCHT

Segment by Type

Child Nasal Spray Vaccine

Adult Nasal Spray Vaccine

Segment by Application

Child

Adult

By Region

Americas

United States

Canada

Mexico

Brazil

China

APAC (excluding China)

Japan

South Korea

China Taiwan

ASEAN

India

EMEA

Europe

Middle East

Africa

Chapter Introduction

Chapter 1: Introduces Nasal Spray Vaccine definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Nasal Spray Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Nasal Spray Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by type, by application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by type, by application and by region, sales, and revenue for each segment.

Chapter 8: China by type, by application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Spray Vaccine sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: Research findings and conclusion

OUR INDIA OFFICE

India Office

315 Work Avenue, Raheja Woods,
Kalyani Nagar, Pune,
Maharashtra 411006, India

Report Overview